U.S. Life Sciences Stock News

NYSE:KGS
NYSE:KGSEnergy Services

Is Kodiak Gas Services (KGS) Pricing Justified After Its Strong Share Price Run?

If you are wondering whether Kodiak Gas Services is still reasonably priced after its strong run, this article will help you make sense of where the stock stands today. The shares recently closed at US$56.72, with returns of 10.8% over the last 30 days, 50.7% year to date, and 61.2% over the past year, alongside a 2.5% decline in the most recent week. Recent news coverage has focused on Kodiak Gas Services as an energy infrastructure name that some investors watch for its role in supporting...
NYSE:ONTO
NYSE:ONTOSemiconductor

Why Onto Innovation (ONTO) Is Down 7.8% After Sector-Wide Chip Equipment Regulatory Jitters And Geopolitical Tensions

In recent days, Onto Innovation has been swept up in a broad semiconductor equipment sector sell-off driven by regulatory concerns, geopolitical tensions, and fines and outlook worries at larger peers Applied Materials and ASML, rather than by any change in its own operations. At the same time, Onto Innovation’s no-debt balance sheet, strong liquidity, and a US$240 million-plus Dragonfly high-bandwidth memory agreement through 2027 underline a business profile that contrasts with the...
NasdaqGS:MDLN
NasdaqGS:MDLNMedical Equipment

Is Medline (MDLN) Offering Value After Recent Share Price Weakness?

If you are wondering whether Medline's current share price reflects its true worth, you are not alone. This article will walk through what the numbers say about value. Medline recently closed at US$42.39, with a 1.1% decline over the last 7 days, a 10.5% decline over 30 days, and a 4.4% gain year to date. These moves may suggest the market is still forming a view on the stock. Recent coverage around Medline has focused on its positioning as a healthcare stock and how investors are treating...
NasdaqGS:NFLX
NasdaqGS:NFLXEntertainment

Netflix Walks From Warner Deal To Refocus On Streaming And AI

Netflix (NasdaqGS:NFLX) has withdrawn from its bid to acquire Warner Bros. Discovery, avoiding a large studio takeover. The company is set to receive a significant breakup fee tied to the terminated deal. Management is signaling renewed focus on organic growth, higher content spending, and its core streaming platform. Recent technology and AI acquisitions are expected to support content production and product development. The decision leaves Netflix with preserved capital while other bidders...
NYSE:RERE
NYSE:RERESpecialty Retail

ATRenew (NYSE:RERE) Margin Turn Reinforces Bullish Profitability Narratives After Fourth Straight Profitable Quarter

ATRenew (NYSE:RERE) just posted another profitable quarter, with Q3 FY 2025 revenue of C¥5.1b and basic EPS of C¥0.38, while trailing twelve month revenue stood at C¥19.6b and basic EPS at C¥1.17 as the business continued to operate in the black across the past year. The company has seen quarterly revenue move from C¥3.8b in Q2 FY 2024 to C¥4.1b in Q3 FY 2024 and then to C¥5.1b in Q3 FY 2025. Basic EPS shifted from a loss of C¥0.04 in Q2 FY 2024 to C¥0.07 in Q3 FY 2024 and then to C¥0.38 in...
NYSE:NVO
NYSE:NVOPharmaceuticals

Assessing Novo Nordisk (NYSE:NVO) After A 47% One-Year Share Price Pullback

If you are wondering whether Novo Nordisk's current share price really reflects what you are getting for your money, this article walks through the numbers so you can judge the value story for yourself. After touching a last close of US$38.83, the stock has seen mixed returns, with a 0.9% gain over 7 days but declines of 21.3% over 30 days, 25.9% year to date, and 47.0% over 1 year. The 5 year return stands at 15.0%. Recent coverage of Novo Nordisk has focused heavily on its role in the...
NYSE:IQV
NYSE:IQVLife Sciences

A Look At IQVIA Holdings (IQV) Valuation After Charles River Deal And Fresh Analyst Coverage

IQVIA Holdings (IQV) is back on investors’ radar after fresh analyst coverage and a planned acquisition of discovery services assets from Charles River Laboratories. These moves directly target its clinical trial and data analytics footprint. See our latest analysis for IQVIA Holdings. Despite fresh interest around the Charles River deal and new analyst coverage, IQVIA’s share price has had a tough run, with a 30 day share price return of 10.95% and a year to date share price return of...
NYSE:UWMC
NYSE:UWMCDiversified Financial

A Look At UWM Holdings (UWMC) Valuation After Recent Share Price Weakness

UWM Holdings (UWMC) has been drawing attention after recent share price pressure, with the stock showing negative returns over the past month and past 3 months as investors reassess the wholesale mortgage lender. See our latest analysis for UWM Holdings. At a share price of $3.91, UWM Holdings has seen pressure build over recent months, with a 30 day share price return of a 15.55% decline and a 1 year total shareholder return of a 27.59% loss suggesting momentum has been fading. If this...
NYSE:MA
NYSE:MADiversified Financial

Mastercard (MA) Valuation Check After Recent Share Price Pullback And Modest Fair Value Gap

Recent share performance and business scale Mastercard (MA) has seen its share price decline over the past week, month, and past 3 months, with returns of about 2%, 6%, and 11% declines, while the 1 year total return is a 3% decline. Over a longer horizon, the stock shows positive total returns across 3 and 5 years, and the company reports annual revenue of about US$32.8b and net income of roughly US$15.0b from its global payments and services business. See our latest analysis for...
NasdaqGS:TRMB
NasdaqGS:TRMBSoftware

Trimble (TRMB) Valuation Check After Q4 And FY 2025 Growth In ARR And Operating Income

Trimble (TRMB) has recently drawn investor attention after its Q4 and FY 2025 results highlighted double digit ARR growth, stronger operating income, and ongoing progress toward its 2027 financial model targets. See our latest analysis for Trimble. Despite solid Q4 and FY 2025 headlines around ARR and operating income, Trimble’s recent share price action has been softer. The 90 day share price return shows an 18.89% decline and the year to date share price return shows a 13.70% decline, while...
NYSE:ABT
NYSE:ABTMedical Equipment

Abbott’s Freedom To Work Plan And What It May Mean For NYSE ABT

Abbott Laboratories has rolled out a phased retirement program called "Freedom to Work" for long tenured employees aged 55 and older. The program allows participants to reduce their working hours while keeping full time benefits. Management reports that the initiative has extended the company’s average retirement age and is now a formal part of Abbott’s workforce policy. For investors watching NYSE:ABT, this people focused move sits alongside a share price of $110.25 and mixed recent...
NYSE:MMM
NYSE:MMMIndustrials

Is 3M’s (MMM) Design-Driven Brite Launch a Meaningful Shift in Its Consumer Brand Strategy?

In early March 2026, 3M launched Brite by Scotch-Brite, a design-focused line of cleaning tools sold through major US retailers and heavily promoted across digital and social channels. This push into more premium, aesthetically driven home-care products highlights how 3M is trying to refresh its consumer brand while broader operations face legal and earnings pressures. Now we’ll examine how this design-led Brite launch fits with 3M’s existing turnaround narrative amid ongoing litigation...
NYSE:IP
NYSE:IPPackaging

International Paper Split Plans Raise Questions On Value And Future Returns

International Paper (NYSE:IP) plans to spin off its EMEA packaging business following its acquisition of DS Smith. The company intends to separate into two independent entities, each focused on different parts of its packaging and paper operations. This planned split signals a shift in how International Paper structures its assets and focuses its operations across regions. International Paper, trading at $38.66, is moving through a period of reorganization at the same time its share price...
NYSE:LEVI
NYSE:LEVILuxury

Levi Strauss Lawsuit Tests Culture Governance And Human Capital Story

Levi Strauss (NYSE:LEVI) is facing an age discrimination lawsuit alleging that the company terminated several employees over 40 and replaced them with younger workers. The complaint claims that these staffing changes were part of broader workforce decisions affecting senior staff at the apparel maker. The case raises questions about Levi Strauss corporate culture and human capital practices at a time when labor issues are drawing closer investor attention. Levi Strauss, known for its denim...
NasdaqGS:EXLS
NasdaqGS:EXLSProfessional Services

EXL’s Agentic AI Suite Aims To Deepen Data Led Client Relationships

EXL (NasdaqGS:EXLS) has rolled out a broad suite of agentic AI solutions designed to help enterprises use AI at scale. The launch includes new autonomous agent building tools, decision intelligence through EXLdecision.ai, and industry specific automation such as EXL ClaimsAssist.ai. These capabilities are integrated into the EXLerate.ai platform to support more repeatable, real world AI deployment across client operations. For you as an investor, this matters because EXL is leaning into its...
NYSE:NOMD
NYSE:NOMDFood

A Look At Nomad Foods (NOMD) Valuation After Earnings Loss And New Shelf Registration

Nomad Foods (NOMD) is in focus after reporting a fourth quarter net loss and lower full year net income, while also filing an omnibus shelf registration that allows future issuance of shares, debt, preferred stock or warrants. See our latest analysis for Nomad Foods. The mixed reaction to Nomad Foods' latest quarterly loss, buyback updates and new shelf registration comes after a 1 day share price return of 1.97%, compared with a 30 day share price return decline of 20.06% and a 1 year total...
NYSE:DHT
NYSE:DHTOil and Gas

Will a Second Hanwha-Built VLCC Delivery and Spot Deployment Redefine DHT Holdings' (DHT) Tanker Narrative?

On 6 March 2026, DHT Holdings took delivery of DHT Addax, its second Hanwha-built VLCC newbuilding, which is fully funded and entering the spot market as part of a four-ship program due in the first half of 2026. This addition of a modern, fuel-efficient VLCC with advanced emissions-compliance features strengthens DHT’s operational capabilities and potential earnings power amid changing crude trade patterns and regulatory pressures. We’ll now explore how this new VLCC delivery, and its...
NasdaqGS:AAL
NasdaqGS:AALAirlines

Is American Airlines (AAL) Using Extended Credit Lines to Buffer Fuel Risk or Mask Vulnerability?

On March 5, 2026, American Airlines and its lenders amended several major credit agreements, replacing older revolving facilities with new commitments totaling about US$3.11 billion and extending maturities to March 5, 2031. By securing longer-dated revolving credit and letter-of-credit capacity, American Airlines has reinforced its access to liquidity at a time when unhedged exposure to rising fuel costs is putting additional pressure on its expenses. Next, we’ll examine how this expanded...
NYSE:DFIN
NYSE:DFINCapital Markets

Can Donnelley Financial (DFIN) Turn Regulatory Complexity Into Durable, High-Quality Recurring Revenue?

Donnelley Financial Solutions recently reported quarterly results that showed 10.4% year-on-year revenue growth and earnings and revenue exceeding analyst expectations, underlining its operational strength in compliance and regulatory software services. This outperformance, coupled with analysts revising earnings estimates upward and maintaining a top-tier Zacks Rank, highlights growing confidence in Donnelley Financial Solutions' ability to convert regulatory complexity into higher-quality...
NYSE:APAM
NYSE:APAMCapital Markets

Is Artisan Partners Asset Management (APAM) Pricing Look Interesting After Recent Share Price Pullback

If you are wondering whether Artisan Partners Asset Management is attractively priced at the moment, you are not alone. Many investors are asking the same question. The stock last closed at US$36.28, with returns of a 9.4% decline over 7 days, a 21.5% decline over 30 days, a 12.4% decline year to date, a 2.6% gain over 1 year, a 55.6% gain over 3 years, and a 3.5% gain over 5 years. Recent headlines around Artisan Partners Asset Management have focused on its role as an active asset manager...
NasdaqGS:FANG
NasdaqGS:FANGOil and Gas

Diamondback Ownership Shifts As SGF FANG Sale Lifts Public Float

SGF FANG Holdings LP sold 11 million shares of Diamondback Energy on the secondary market. The transaction totaled about US$1.9b and Diamondback Energy received no proceeds from the sale. The deal materially changes the ownership profile of Diamondback Energy, ticker NasdaqGS:FANG, and increases the public float. Diamondback Energy focuses on oil and gas production, with a core position in the US shale sector. For you as an investor, the key point here is that this was an existing owner...
NYSE:WTI
NYSE:WTIOil and Gas

Assessing W&T Offshore (WTI) Valuation After 2025 Earnings Reveal Lower Revenue And Wider Net Loss

Earnings snapshot and dividend update W&T Offshore (WTI) has drawn fresh attention after reporting fourth quarter and full year 2025 results, with lower annual revenue, a larger net loss, and a maintained quarterly dividend. See our latest analysis for W&T Offshore. The latest earnings release and the recent affirmation of the US$0.01 quarterly dividend came alongside a 67.65% 3 month share price return and a 94.69% 1 year total shareholder return. However, the 3 year total shareholder return...
NYSE:VICI
NYSE:VICISpecialized REITs

Tilman Fertitta Caesars Talks Put VICI Properties Lease Outlook In Focus

Tilman Fertitta is in exclusive talks to acquire Caesars Entertainment, a core tenant of NYSE:VICI. The discussions focus on a potential company wide takeover of Caesars, which operates multiple casino and entertainment properties tied to VICI leases. The outcome could influence rental terms, property usage, and future capital plans across VICI owned real estate connected to Caesars. For you as an investor, this matters because VICI Properties is a major casino and experiential REIT, and...
NYSE:EW
NYSE:EWMedical Equipment

A Look At Edwards Lifesciences (EW) Valuation As It Exits Critical Care To Focus On Core Heart Therapies

Edwards Lifesciences (EW) has been back in focus after moving to sell its critical care unit and to concentrate on areas such as asymptomatic aortic stenosis and structural heart failure, along with fresh Q4 numbers. See our latest analysis for Edwards Lifesciences. The recent decision to sell the critical care unit, Q4 results, and the appointment of a new Director of Government Affairs have all come as Edwards Lifesciences posts a 10.79% 1 month share price return and a 24.20% 1 year total...